Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. | Semantic Scholar
Pneumocystis jiroveci pneumonia Information | Mount Sinai - New York
Pneumocystis Pneumonia | NEJM
Non‐HIV‐infected patients with Pneumocystis pneumonia in the intensive care unit: A bicentric, retrospective study focused on predictive factors of in‐hospital mortality - Wang - 2022 - The Clinical Respiratory Journal - Wiley
Pneumocystis Jirovecii Pneumonia - Physiopedia
Discontinuation of Pneumocystis jirovecii Pneumonia Prophylaxis with CD4 Count <200 Cells/µL and Virologic Suppression: A Systematic Review | PLOS ONE
Association of time-to-treatment with outcomes of Pneumocystis pneumonia with respiratory failure in HIV-negative patients | Respiratory Research | Full Text
Discontinuation of Pneumocystis carinii pneumonia prophylaxis after start of highly active antiretroviral therapy in HIV-1 infection - The Lancet
IJERPH | Free Full-Text | Trimethoprim-Sulfamethoxazole (Bactrim) Dose Optimization in Pneumocystis jirovecii Pneumonia (PCP) Management: A Systematic Review
Pneumocystis jirovecii Pneumonia: Epidemiology, Clinical Manifestation and Diagnosis | SpringerLink
Drugs for Prophylaxis against Pneumocystis Pneumonia. | Download Table
Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients | European Respiratory Society
New Page 0
Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years | Critical Care | Full Text